Cafodase 15 Tablet contains Serratiopeptidase 15 mg, a proteolytic enzyme widely used for its anti-inflammatory and anti-edematous properties. The medicine helps reduce inflammation, swelling, and tissue fluid accumulation associated with various medical and surgical conditions. By supporting the body's natural healing process, it contributes to improved recovery and relief from discomfort resulting from inflammatory conditions.
Serratiopeptidase works by breaking down inflammatory proteins and facilitating the removal of damaged tissue debris from affected areas. This action helps reduce swelling, improve tissue drainage, and support faster resolution of inflammation. The enzyme is frequently used as an adjunctive therapy in orthopedic, dental, ENT, and postoperative care where inflammation and swelling are common concerns. Its unique enzymatic mechanism provides supportive benefits without directly acting as a conventional painkiller.
The tablet is commonly prescribed for inflammatory conditions involving soft tissues, joints, muscles, postoperative swelling, trauma-related injuries, sinus inflammation, and dental procedures as advised by a healthcare professional. Regular use according to medical guidance may help improve recovery, reduce swelling, and enhance patient comfort. The treatment plan should be tailored to the individual's condition and therapeutic needs.
With the growing demand for supportive anti-inflammatory therapies and postoperative recovery solutions, Cafodase 15 Tablet maintains strong demand in the pain management and orthopedic segments. Its established clinical utility, physician confidence, and broad range of applications contribute to consistent market potential. The product offers valuable business opportunities and sustainable growth prospects for retailers and distributors operating within the pharmaceutical anti-inflammatory sector.